West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
211.47
+0.83 (0.39%)
Jun 4, 2025, 11:53 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Proprietary Products
2.34B
Log In
Log In
Log In
Log In
Upgrade
Proprietary Products Growth
-1.50%
Log In
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products
557.80M
Log In
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products Growth
0.52%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Proprietary Products Operating Profit
582.10M
Log In
Log In
Log In
Log In
Upgrade
Proprietary Products Operating Profit Growth
-12.56%
Log In
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products Operating Profit
68.70M
Log In
Log In
Log In
Log In
Upgrade
Contract-Manufactured Products Operating Profit Growth
-4.32%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2019
Organic Net Sales Growth
Log In
Log In
Log In
Log In
Upgrade